ZL-1201-001: Trial of ZL-1201 in Subjects With Advanced Cancer
Condition: Solid Tumor or Lymphoma
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Protocol ZL-1201-001. First in Human, Phase I Trial of Anti-CD47 Antibody ZL-1201 in Subjects with Advanced Cancer. A study for patients with previously treated advanced or metastatic solid tumors or lymphoma.
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.